nodes	percent_of_prediction	percent_of_DWPC	metapath
Amsacrine—ABCB1—melanoma	0.439	1	CbGaD
Amsacrine—CYP2D6—Vemurafenib—melanoma	0.0582	0.483	CbGbCtD
Amsacrine—ABCB1—Dactinomycin—melanoma	0.041	0.341	CbGbCtD
Amsacrine—ABCB1—Docetaxel—melanoma	0.0212	0.176	CbGbCtD
Amsacrine—TOP2A—Paclitaxel—Docetaxel—melanoma	0.00497	1	CbGdCrCtD
Amsacrine—NCOA3—hair follicle—melanoma	0.004	0.254	CbGeAlD
Amsacrine—NCOA3—neck—melanoma	0.00268	0.17	CbGeAlD
Amsacrine—NCOA3—retina—melanoma	0.00198	0.126	CbGeAlD
Amsacrine—NCOA3—mammalian vulva—melanoma	0.00158	0.101	CbGeAlD
Amsacrine—Sepsis—Dactinomycin—melanoma	0.00157	0.00606	CcSEcCtD
Amsacrine—Aplastic anaemia—Temozolomide—melanoma	0.00154	0.00593	CcSEcCtD
Amsacrine—Phlebitis—Dactinomycin—melanoma	0.00152	0.00589	CcSEcCtD
Amsacrine—Cardiac disorder—Vemurafenib—melanoma	0.00149	0.00576	CcSEcCtD
Amsacrine—Sepsis—Carmustine—melanoma	0.00147	0.00567	CcSEcCtD
Amsacrine—Hepatic failure—Dactinomycin—melanoma	0.00146	0.00564	CcSEcCtD
Amsacrine—Angiopathy—Vemurafenib—melanoma	0.00146	0.00563	CcSEcCtD
Amsacrine—Mediastinal disorder—Vemurafenib—melanoma	0.00145	0.0056	CcSEcCtD
Amsacrine—Phlebitis—Carmustine—melanoma	0.00143	0.00551	CcSEcCtD
Amsacrine—Alopecia—Vemurafenib—melanoma	0.00142	0.00549	CcSEcCtD
Amsacrine—Hepatotoxicity—Docetaxel—melanoma	0.00141	0.00544	CcSEcCtD
Amsacrine—Malnutrition—Vemurafenib—melanoma	0.0014	0.00541	CcSEcCtD
Amsacrine—Necrosis—Docetaxel—melanoma	0.00139	0.00535	CcSEcCtD
Amsacrine—Blood alkaline phosphatase increased—Temozolomide—melanoma	0.00136	0.00527	CcSEcCtD
Amsacrine—Lethargy—Dactinomycin—melanoma	0.00134	0.00518	CcSEcCtD
Amsacrine—Vascular purpura—Temozolomide—melanoma	0.00133	0.00513	CcSEcCtD
Amsacrine—Hepatic failure—Temozolomide—melanoma	0.00132	0.0051	CcSEcCtD
Amsacrine—Extravasation—Docetaxel—melanoma	0.00125	0.00482	CcSEcCtD
Amsacrine—Purpura—Temozolomide—melanoma	0.00123	0.00476	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00118	0.00457	CcSEcCtD
Amsacrine—Aspartate aminotransferase increased—Dactinomycin—melanoma	0.00118	0.00457	CcSEcCtD
Amsacrine—Affect lability—Temozolomide—melanoma	0.00117	0.00452	CcSEcCtD
Amsacrine—Pancytopenia—Bleomycin—melanoma	0.00116	0.00446	CcSEcCtD
Amsacrine—Blood bilirubin increased—Docetaxel—melanoma	0.00115	0.00444	CcSEcCtD
Amsacrine—Dysphagia—Dactinomycin—melanoma	0.00113	0.00438	CcSEcCtD
Amsacrine—Infection—Vemurafenib—melanoma	0.00113	0.00438	CcSEcCtD
Amsacrine—NCOA3—head—melanoma	0.00113	0.0719	CbGeAlD
Amsacrine—Mood swings—Temozolomide—melanoma	0.00112	0.00435	CcSEcCtD
Amsacrine—Inflammation—Docetaxel—melanoma	0.00112	0.00433	CcSEcCtD
Amsacrine—Skin disorder—Vemurafenib—melanoma	0.00111	0.00428	CcSEcCtD
Amsacrine—Weight decreased—Bleomycin—melanoma	0.0011	0.00425	CcSEcCtD
Amsacrine—Phosphatase alkaline increased—Docetaxel—melanoma	0.00109	0.0042	CcSEcCtD
Amsacrine—Injection site reaction—Docetaxel—melanoma	0.00108	0.00418	CcSEcCtD
Amsacrine—Pancytopenia—Dactinomycin—melanoma	0.00108	0.00416	CcSEcCtD
Amsacrine—Aspartate aminotransferase increased—Temozolomide—melanoma	0.00107	0.00413	CcSEcCtD
Amsacrine—Hypotension—Vemurafenib—melanoma	0.00107	0.00412	CcSEcCtD
Amsacrine—Dysphagia—Carmustine—melanoma	0.00106	0.0041	CcSEcCtD
Amsacrine—Stomatitis—Bleomycin—melanoma	0.00106	0.00408	CcSEcCtD
Amsacrine—Haematuria—Bleomycin—melanoma	0.00103	0.004	CcSEcCtD
Amsacrine—Dysphagia—Temozolomide—melanoma	0.00103	0.00396	CcSEcCtD
Amsacrine—Pancytopenia—Carmustine—melanoma	0.00101	0.0039	CcSEcCtD
Amsacrine—Decreased appetite—Vemurafenib—melanoma	0.000993	0.00383	CcSEcCtD
Amsacrine—Stomatitis—Dactinomycin—melanoma	0.000986	0.00381	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Vemurafenib—melanoma	0.000986	0.00381	CcSEcCtD
Amsacrine—Fatigue—Vemurafenib—melanoma	0.000984	0.0038	CcSEcCtD
Amsacrine—Haemoglobin—Bleomycin—melanoma	0.000979	0.00378	CcSEcCtD
Amsacrine—Pancytopenia—Temozolomide—melanoma	0.000974	0.00377	CcSEcCtD
Amsacrine—Haemorrhage—Bleomycin—melanoma	0.000974	0.00376	CcSEcCtD
Amsacrine—Hypoaesthesia—Bleomycin—melanoma	0.000969	0.00374	CcSEcCtD
Amsacrine—Agranulocytosis—Dactinomycin—melanoma	0.000944	0.00365	CcSEcCtD
Amsacrine—Sepsis—Docetaxel—melanoma	0.000944	0.00365	CcSEcCtD
Amsacrine—Weight increased—Temozolomide—melanoma	0.000934	0.00361	CcSEcCtD
Amsacrine—Renal failure—Carmustine—melanoma	0.000931	0.0036	CcSEcCtD
Amsacrine—Weight decreased—Temozolomide—melanoma	0.000928	0.00359	CcSEcCtD
Amsacrine—TOP2A—mammalian vulva—melanoma	0.000928	0.059	CbGeAlD
Amsacrine—Stomatitis—Carmustine—melanoma	0.000923	0.00357	CcSEcCtD
Amsacrine—Phlebitis—Docetaxel—melanoma	0.000916	0.00354	CcSEcCtD
Amsacrine—Infestation—Temozolomide—melanoma	0.000915	0.00353	CcSEcCtD
Amsacrine—Infestation NOS—Temozolomide—melanoma	0.000915	0.00353	CcSEcCtD
Amsacrine—Hepatitis—Dactinomycin—melanoma	0.000908	0.00351	CcSEcCtD
Amsacrine—Blood alkaline phosphatase increased—Docetaxel—melanoma	0.000908	0.00351	CcSEcCtD
Amsacrine—Body temperature increased—Vemurafenib—melanoma	0.000903	0.00349	CcSEcCtD
Amsacrine—Stomatitis—Temozolomide—melanoma	0.000892	0.00345	CcSEcCtD
Amsacrine—Hepatic failure—Docetaxel—melanoma	0.000879	0.00339	CcSEcCtD
Amsacrine—Cardiac failure congestive—Docetaxel—melanoma	0.000871	0.00336	CcSEcCtD
Amsacrine—Hepatobiliary disease—Temozolomide—melanoma	0.000865	0.00334	CcSEcCtD
Amsacrine—Alopecia—Bleomycin—melanoma	0.00086	0.00332	CcSEcCtD
Amsacrine—Haemoglobin—Carmustine—melanoma	0.000854	0.0033	CcSEcCtD
Amsacrine—Haemorrhage—Carmustine—melanoma	0.00085	0.00328	CcSEcCtD
Amsacrine—Hypoaesthesia—Carmustine—melanoma	0.000846	0.00327	CcSEcCtD
Amsacrine—Hypersensitivity—Vemurafenib—melanoma	0.000841	0.00325	CcSEcCtD
Amsacrine—Connective tissue disorder—Carmustine—melanoma	0.000835	0.00323	CcSEcCtD
Amsacrine—Atrial fibrillation—Docetaxel—melanoma	0.000833	0.00322	CcSEcCtD
Amsacrine—Haemoglobin—Temozolomide—melanoma	0.000826	0.00319	CcSEcCtD
Amsacrine—Haemorrhage—Temozolomide—melanoma	0.000821	0.00317	CcSEcCtD
Amsacrine—Hepatitis—Temozolomide—melanoma	0.000821	0.00317	CcSEcCtD
Amsacrine—Asthenia—Vemurafenib—melanoma	0.000819	0.00317	CcSEcCtD
Amsacrine—Hypoaesthesia—Temozolomide—melanoma	0.000817	0.00316	CcSEcCtD
Amsacrine—Urinary tract disorder—Temozolomide—melanoma	0.000811	0.00313	CcSEcCtD
Amsacrine—Connective tissue disorder—Temozolomide—melanoma	0.000807	0.00312	CcSEcCtD
Amsacrine—Lethargy—Docetaxel—melanoma	0.000806	0.00311	CcSEcCtD
Amsacrine—Urethral disorder—Temozolomide—melanoma	0.000805	0.00311	CcSEcCtD
Amsacrine—Alopecia—Dactinomycin—melanoma	0.000802	0.0031	CcSEcCtD
Amsacrine—NCOA3—lymph node—melanoma	0.000793	0.0504	CbGeAlD
Amsacrine—Anaemia—Bleomycin—melanoma	0.000783	0.00303	CcSEcCtD
Amsacrine—Diarrhoea—Vemurafenib—melanoma	0.000781	0.00302	CcSEcCtD
Amsacrine—Cardiac disorder—Temozolomide—melanoma	0.000762	0.00295	CcSEcCtD
Amsacrine—Arrhythmia—Carmustine—melanoma	0.000759	0.00293	CcSEcCtD
Amsacrine—Leukopenia—Bleomycin—melanoma	0.000759	0.00293	CcSEcCtD
Amsacrine—Dizziness—Vemurafenib—melanoma	0.000755	0.00292	CcSEcCtD
Amsacrine—Alopecia—Carmustine—melanoma	0.000751	0.0029	CcSEcCtD
Amsacrine—Angiopathy—Temozolomide—melanoma	0.000745	0.00288	CcSEcCtD
Amsacrine—Mental disorder—Carmustine—melanoma	0.000745	0.00288	CcSEcCtD
Amsacrine—Mediastinal disorder—Temozolomide—melanoma	0.00074	0.00286	CcSEcCtD
Amsacrine—Malnutrition—Carmustine—melanoma	0.00074	0.00286	CcSEcCtD
Amsacrine—Anaemia—Dactinomycin—melanoma	0.000731	0.00282	CcSEcCtD
Amsacrine—Vomiting—Vemurafenib—melanoma	0.000726	0.0028	CcSEcCtD
Amsacrine—Alopecia—Temozolomide—melanoma	0.000726	0.0028	CcSEcCtD
Amsacrine—Rash—Vemurafenib—melanoma	0.00072	0.00278	CcSEcCtD
Amsacrine—Mental disorder—Temozolomide—melanoma	0.00072	0.00278	CcSEcCtD
Amsacrine—Dermatitis—Vemurafenib—melanoma	0.000719	0.00278	CcSEcCtD
Amsacrine—Headache—Vemurafenib—melanoma	0.000715	0.00276	CcSEcCtD
Amsacrine—Malnutrition—Temozolomide—melanoma	0.000715	0.00276	CcSEcCtD
Amsacrine—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000711	0.00275	CcSEcCtD
Amsacrine—Leukopenia—Dactinomycin—melanoma	0.000708	0.00273	CcSEcCtD
Amsacrine—Confusional state—Bleomycin—melanoma	0.000698	0.00269	CcSEcCtD
Amsacrine—Vision blurred—Carmustine—melanoma	0.000697	0.00269	CcSEcCtD
Amsacrine—Infection—Bleomycin—melanoma	0.000687	0.00266	CcSEcCtD
Amsacrine—Anaemia—Carmustine—melanoma	0.000684	0.00264	CcSEcCtD
Amsacrine—Dysphagia—Docetaxel—melanoma	0.000682	0.00264	CcSEcCtD
Amsacrine—Nausea—Vemurafenib—melanoma	0.000678	0.00262	CcSEcCtD
Amsacrine—Thrombocytopenia—Bleomycin—melanoma	0.000677	0.00262	CcSEcCtD
Amsacrine—Vision blurred—Temozolomide—melanoma	0.000674	0.0026	CcSEcCtD
Amsacrine—Leukopenia—Carmustine—melanoma	0.000662	0.00256	CcSEcCtD
Amsacrine—Anaemia—Temozolomide—melanoma	0.000661	0.00255	CcSEcCtD
Amsacrine—Anorexia—Bleomycin—melanoma	0.000659	0.00255	CcSEcCtD
Amsacrine—Pancytopenia—Docetaxel—melanoma	0.000648	0.0025	CcSEcCtD
Amsacrine—Hypotension—Bleomycin—melanoma	0.000646	0.0025	CcSEcCtD
Amsacrine—Convulsion—Carmustine—melanoma	0.000641	0.00248	CcSEcCtD
Amsacrine—Infection—Dactinomycin—melanoma	0.000641	0.00248	CcSEcCtD
Amsacrine—Leukopenia—Temozolomide—melanoma	0.00064	0.00247	CcSEcCtD
Amsacrine—Thrombocytopenia—Dactinomycin—melanoma	0.000632	0.00244	CcSEcCtD
Amsacrine—Paraesthesia—Bleomycin—melanoma	0.000621	0.0024	CcSEcCtD
Amsacrine—Weight increased—Docetaxel—melanoma	0.000621	0.0024	CcSEcCtD
Amsacrine—Convulsion—Temozolomide—melanoma	0.000619	0.00239	CcSEcCtD
Amsacrine—Weight decreased—Docetaxel—melanoma	0.000617	0.00239	CcSEcCtD
Amsacrine—Dyspnoea—Bleomycin—melanoma	0.000617	0.00238	CcSEcCtD
Amsacrine—Anorexia—Dactinomycin—melanoma	0.000615	0.00238	CcSEcCtD
Amsacrine—Confusional state—Carmustine—melanoma	0.000609	0.00235	CcSEcCtD
Amsacrine—Infestation—Docetaxel—melanoma	0.000608	0.00235	CcSEcCtD
Amsacrine—Infestation NOS—Docetaxel—melanoma	0.000608	0.00235	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000605	0.00234	CcSEcCtD
Amsacrine—Decreased appetite—Bleomycin—melanoma	0.000601	0.00232	CcSEcCtD
Amsacrine—Infection—Carmustine—melanoma	0.0006	0.00232	CcSEcCtD
Amsacrine—Renal failure—Docetaxel—melanoma	0.000598	0.00231	CcSEcCtD
Amsacrine—Stomatitis—Docetaxel—melanoma	0.000593	0.00229	CcSEcCtD
Amsacrine—Jaundice—Docetaxel—melanoma	0.000593	0.00229	CcSEcCtD
Amsacrine—Pain—Bleomycin—melanoma	0.000592	0.00229	CcSEcCtD
Amsacrine—Thrombocytopenia—Carmustine—melanoma	0.000591	0.00228	CcSEcCtD
Amsacrine—Tachycardia—Carmustine—melanoma	0.000589	0.00228	CcSEcCtD
Amsacrine—Confusional state—Temozolomide—melanoma	0.000588	0.00227	CcSEcCtD
Amsacrine—Infection—Temozolomide—melanoma	0.00058	0.00224	CcSEcCtD
Amsacrine—Anorexia—Carmustine—melanoma	0.000576	0.00222	CcSEcCtD
Amsacrine—Hepatobiliary disease—Docetaxel—melanoma	0.000575	0.00222	CcSEcCtD
Amsacrine—Thrombocytopenia—Temozolomide—melanoma	0.000571	0.00221	CcSEcCtD
Amsacrine—Feeling abnormal—Bleomycin—melanoma	0.00057	0.0022	CcSEcCtD
Amsacrine—Agranulocytosis—Docetaxel—melanoma	0.000568	0.00219	CcSEcCtD
Amsacrine—Skin disorder—Temozolomide—melanoma	0.000567	0.00219	CcSEcCtD
Amsacrine—Hypotension—Carmustine—melanoma	0.000564	0.00218	CcSEcCtD
Amsacrine—Decreased appetite—Dactinomycin—melanoma	0.000561	0.00217	CcSEcCtD
Amsacrine—Fatigue—Dactinomycin—melanoma	0.000556	0.00215	CcSEcCtD
Amsacrine—Anorexia—Temozolomide—melanoma	0.000556	0.00215	CcSEcCtD
Amsacrine—Pain—Dactinomycin—melanoma	0.000552	0.00213	CcSEcCtD
Amsacrine—Urticaria—Bleomycin—melanoma	0.00055	0.00212	CcSEcCtD
Amsacrine—Haemoglobin—Docetaxel—melanoma	0.000549	0.00212	CcSEcCtD
Amsacrine—Body temperature increased—Bleomycin—melanoma	0.000547	0.00211	CcSEcCtD
Amsacrine—Haemorrhage—Docetaxel—melanoma	0.000546	0.00211	CcSEcCtD
Amsacrine—Hepatitis—Docetaxel—melanoma	0.000546	0.00211	CcSEcCtD
Amsacrine—Hypoaesthesia—Docetaxel—melanoma	0.000543	0.0021	CcSEcCtD
Amsacrine—Paraesthesia—Carmustine—melanoma	0.000542	0.00209	CcSEcCtD
Amsacrine—ABCB1—blood vessel—melanoma	0.00054	0.0343	CbGeAlD
Amsacrine—Urinary tract disorder—Docetaxel—melanoma	0.000539	0.00208	CcSEcCtD
Amsacrine—Dyspnoea—Carmustine—melanoma	0.000538	0.00208	CcSEcCtD
Amsacrine—Connective tissue disorder—Docetaxel—melanoma	0.000537	0.00207	CcSEcCtD
Amsacrine—Urethral disorder—Docetaxel—melanoma	0.000535	0.00207	CcSEcCtD
Amsacrine—Feeling abnormal—Dactinomycin—melanoma	0.000532	0.00205	CcSEcCtD
Amsacrine—Gastrointestinal pain—Dactinomycin—melanoma	0.000528	0.00204	CcSEcCtD
Amsacrine—Decreased appetite—Carmustine—melanoma	0.000525	0.00203	CcSEcCtD
Amsacrine—Paraesthesia—Temozolomide—melanoma	0.000524	0.00202	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Carmustine—melanoma	0.000521	0.00201	CcSEcCtD
Amsacrine—Dyspnoea—Temozolomide—melanoma	0.00052	0.00201	CcSEcCtD
Amsacrine—Pain—Carmustine—melanoma	0.000516	0.002	CcSEcCtD
Amsacrine—Abdominal pain—Dactinomycin—melanoma	0.00051	0.00197	CcSEcCtD
Amsacrine—Body temperature increased—Dactinomycin—melanoma	0.00051	0.00197	CcSEcCtD
Amsacrine—Hypersensitivity—Bleomycin—melanoma	0.00051	0.00197	CcSEcCtD
Amsacrine—Decreased appetite—Temozolomide—melanoma	0.000507	0.00196	CcSEcCtD
Amsacrine—Cardiac disorder—Docetaxel—melanoma	0.000507	0.00196	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Temozolomide—melanoma	0.000504	0.00195	CcSEcCtD
Amsacrine—Fatigue—Temozolomide—melanoma	0.000503	0.00194	CcSEcCtD
Amsacrine—Pain—Temozolomide—melanoma	0.000499	0.00193	CcSEcCtD
Amsacrine—Feeling abnormal—Carmustine—melanoma	0.000498	0.00192	CcSEcCtD
Amsacrine—Asthenia—Bleomycin—melanoma	0.000496	0.00192	CcSEcCtD
Amsacrine—Angiopathy—Docetaxel—melanoma	0.000496	0.00191	CcSEcCtD
Amsacrine—Gastrointestinal pain—Carmustine—melanoma	0.000494	0.00191	CcSEcCtD
Amsacrine—Mediastinal disorder—Docetaxel—melanoma	0.000492	0.0019	CcSEcCtD
Amsacrine—Arrhythmia—Docetaxel—melanoma	0.000488	0.00189	CcSEcCtD
Amsacrine—Alopecia—Docetaxel—melanoma	0.000483	0.00186	CcSEcCtD
Amsacrine—Feeling abnormal—Temozolomide—melanoma	0.000481	0.00186	CcSEcCtD
Amsacrine—Mental disorder—Docetaxel—melanoma	0.000479	0.00185	CcSEcCtD
Amsacrine—Abdominal pain—Carmustine—melanoma	0.000477	0.00184	CcSEcCtD
Amsacrine—Body temperature increased—Carmustine—melanoma	0.000477	0.00184	CcSEcCtD
Amsacrine—Gastrointestinal pain—Temozolomide—melanoma	0.000477	0.00184	CcSEcCtD
Amsacrine—Malnutrition—Docetaxel—melanoma	0.000475	0.00184	CcSEcCtD
Amsacrine—Hypersensitivity—Dactinomycin—melanoma	0.000475	0.00184	CcSEcCtD
Amsacrine—TOP2A—lymph node—melanoma	0.000465	0.0295	CbGeAlD
Amsacrine—Urticaria—Temozolomide—melanoma	0.000464	0.00179	CcSEcCtD
Amsacrine—Asthenia—Dactinomycin—melanoma	0.000463	0.00179	CcSEcCtD
Amsacrine—Abdominal pain—Temozolomide—melanoma	0.000461	0.00178	CcSEcCtD
Amsacrine—Body temperature increased—Temozolomide—melanoma	0.000461	0.00178	CcSEcCtD
Amsacrine—Hypersensitivity—Carmustine—melanoma	0.000445	0.00172	CcSEcCtD
Amsacrine—Diarrhoea—Dactinomycin—melanoma	0.000441	0.00171	CcSEcCtD
Amsacrine—Vomiting—Bleomycin—melanoma	0.00044	0.0017	CcSEcCtD
Amsacrine—Anaemia—Docetaxel—melanoma	0.000439	0.0017	CcSEcCtD
Amsacrine—Rash—Bleomycin—melanoma	0.000436	0.00169	CcSEcCtD
Amsacrine—Dermatitis—Bleomycin—melanoma	0.000436	0.00168	CcSEcCtD
Amsacrine—Asthenia—Carmustine—melanoma	0.000433	0.00167	CcSEcCtD
Amsacrine—Hypersensitivity—Temozolomide—melanoma	0.00043	0.00166	CcSEcCtD
Amsacrine—Leukopenia—Docetaxel—melanoma	0.000426	0.00164	CcSEcCtD
Amsacrine—Asthenia—Temozolomide—melanoma	0.000419	0.00162	CcSEcCtD
Amsacrine—Diarrhoea—Carmustine—melanoma	0.000413	0.0016	CcSEcCtD
Amsacrine—Convulsion—Docetaxel—melanoma	0.000412	0.00159	CcSEcCtD
Amsacrine—Nausea—Bleomycin—melanoma	0.000411	0.00159	CcSEcCtD
Amsacrine—Vomiting—Dactinomycin—melanoma	0.00041	0.00158	CcSEcCtD
Amsacrine—Rash—Dactinomycin—melanoma	0.000407	0.00157	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000402	0.00155	CcSEcCtD
Amsacrine—Dizziness—Carmustine—melanoma	0.000399	0.00154	CcSEcCtD
Amsacrine—Diarrhoea—Temozolomide—melanoma	0.000399	0.00154	CcSEcCtD
Amsacrine—Confusional state—Docetaxel—melanoma	0.000391	0.00151	CcSEcCtD
Amsacrine—Dizziness—Temozolomide—melanoma	0.000386	0.00149	CcSEcCtD
Amsacrine—Infection—Docetaxel—melanoma	0.000386	0.00149	CcSEcCtD
Amsacrine—Vomiting—Carmustine—melanoma	0.000384	0.00148	CcSEcCtD
Amsacrine—Nausea—Dactinomycin—melanoma	0.000383	0.00148	CcSEcCtD
Amsacrine—Rash—Carmustine—melanoma	0.000381	0.00147	CcSEcCtD
Amsacrine—Dermatitis—Carmustine—melanoma	0.00038	0.00147	CcSEcCtD
Amsacrine—Thrombocytopenia—Docetaxel—melanoma	0.00038	0.00147	CcSEcCtD
Amsacrine—Tachycardia—Docetaxel—melanoma	0.000379	0.00146	CcSEcCtD
Amsacrine—Headache—Carmustine—melanoma	0.000378	0.00146	CcSEcCtD
Amsacrine—Skin disorder—Docetaxel—melanoma	0.000377	0.00146	CcSEcCtD
Amsacrine—KCNH2—head—melanoma	0.000372	0.0236	CbGeAlD
Amsacrine—Vomiting—Temozolomide—melanoma	0.000371	0.00143	CcSEcCtD
Amsacrine—Anorexia—Docetaxel—melanoma	0.00037	0.00143	CcSEcCtD
Amsacrine—Rash—Temozolomide—melanoma	0.000368	0.00142	CcSEcCtD
Amsacrine—Dermatitis—Temozolomide—melanoma	0.000368	0.00142	CcSEcCtD
Amsacrine—Headache—Temozolomide—melanoma	0.000366	0.00141	CcSEcCtD
Amsacrine—Hypotension—Docetaxel—melanoma	0.000363	0.0014	CcSEcCtD
Amsacrine—Nausea—Carmustine—melanoma	0.000359	0.00139	CcSEcCtD
Amsacrine—Paraesthesia—Docetaxel—melanoma	0.000348	0.00135	CcSEcCtD
Amsacrine—Nausea—Temozolomide—melanoma	0.000347	0.00134	CcSEcCtD
Amsacrine—Dyspnoea—Docetaxel—melanoma	0.000346	0.00134	CcSEcCtD
Amsacrine—Decreased appetite—Docetaxel—melanoma	0.000337	0.0013	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Docetaxel—melanoma	0.000335	0.00129	CcSEcCtD
Amsacrine—Fatigue—Docetaxel—melanoma	0.000335	0.00129	CcSEcCtD
Amsacrine—Pain—Docetaxel—melanoma	0.000332	0.00128	CcSEcCtD
Amsacrine—Feeling abnormal—Docetaxel—melanoma	0.00032	0.00124	CcSEcCtD
Amsacrine—Gastrointestinal pain—Docetaxel—melanoma	0.000317	0.00123	CcSEcCtD
Amsacrine—Body temperature increased—Docetaxel—melanoma	0.000307	0.00119	CcSEcCtD
Amsacrine—Abdominal pain—Docetaxel—melanoma	0.000307	0.00119	CcSEcCtD
Amsacrine—Hypersensitivity—Docetaxel—melanoma	0.000286	0.0011	CcSEcCtD
Amsacrine—ABCB1—retina—melanoma	0.000285	0.0181	CbGeAlD
Amsacrine—Asthenia—Docetaxel—melanoma	0.000278	0.00108	CcSEcCtD
Amsacrine—Diarrhoea—Docetaxel—melanoma	0.000266	0.00103	CcSEcCtD
Amsacrine—KCNH2—lymph node—melanoma	0.000261	0.0166	CbGeAlD
Amsacrine—Dizziness—Docetaxel—melanoma	0.000257	0.000991	CcSEcCtD
Amsacrine—Vomiting—Docetaxel—melanoma	0.000247	0.000953	CcSEcCtD
Amsacrine—Rash—Docetaxel—melanoma	0.000245	0.000945	CcSEcCtD
Amsacrine—Dermatitis—Docetaxel—melanoma	0.000244	0.000944	CcSEcCtD
Amsacrine—Headache—Docetaxel—melanoma	0.000243	0.000939	CcSEcCtD
Amsacrine—Nausea—Docetaxel—melanoma	0.00023	0.000891	CcSEcCtD
Amsacrine—ABCB1—mammalian vulva—melanoma	0.000228	0.0145	CbGeAlD
Amsacrine—CYP2D6—head—melanoma	0.000227	0.0144	CbGeAlD
Amsacrine—ABCB1—head—melanoma	0.000163	0.0104	CbGeAlD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—APAF1—melanoma	0.000149	0.000922	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	0.000148	0.000919	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	0.000148	0.000914	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—CXCL8—melanoma	0.000147	0.000913	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—FASLG—melanoma	0.000147	0.000912	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—ERBB2—melanoma	0.000146	0.000904	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—ALB—melanoma	0.000146	0.000902	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—AURKA—melanoma	0.000144	0.000893	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—FAS—melanoma	0.000142	0.00088	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—GNA11—melanoma	0.000141	0.000875	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—CASP3—melanoma	0.000141	0.000874	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—melanoma	0.000141	0.000874	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	0.000141	0.000873	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—NOS2—melanoma	0.00014	0.000869	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—APEX1—melanoma	0.00014	0.000868	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—HLA-A—melanoma	0.00014	0.000865	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	0.000139	0.00086	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—ARL2—melanoma	0.000138	0.000857	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—FASN—melanoma	0.000138	0.000857	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	0.000137	0.000848	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—SLC5A5—melanoma	0.000136	0.000843	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—CTNNB1—melanoma	0.000136	0.000842	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	0.000134	0.000829	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—NFKB1—melanoma	0.000132	0.000817	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—GNAQ—melanoma	0.000131	0.000814	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—CD44—melanoma	0.000131	0.000814	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	0.000129	0.000797	CbGpPWpGaD
Amsacrine—TOP2A—Mitotic G1-G1/S phases—MYC—melanoma	0.000128	0.000793	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—CTNNB1—melanoma	0.000128	0.000791	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—HLA-DRB1—melanoma	0.000128	0.00079	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—PTGS2—melanoma	0.000128	0.00079	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	0.000127	0.000785	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—CYP1B1—melanoma	0.000126	0.00078	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—APEX1—melanoma	0.000125	0.000776	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—MMP9—melanoma	0.000125	0.000776	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	0.000124	0.000769	CbGpPWpGaD
Amsacrine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—melanoma	0.000124	0.000768	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—NFKB1—melanoma	0.000124	0.000767	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—CDKN2B—melanoma	0.000121	0.00075	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	0.000121	0.000749	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	0.00012	0.000742	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—VEGFA—melanoma	0.00012	0.000741	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—CYP17A1—melanoma	0.000119	0.000737	CbGpPWpGaD
Amsacrine—KCNH2—Neuronal System—BRAF—melanoma	0.000118	0.000732	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—CD80—melanoma	0.000118	0.00073	CbGpPWpGaD
Amsacrine—CYP2D6—Metapathway biotransformation—CYP17A1—melanoma	0.000117	0.000727	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	0.000117	0.000725	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	0.000117	0.000723	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	0.000116	0.000719	CbGpPWpGaD
Amsacrine—ABCB1—lymph node—melanoma	0.000114	0.00726	CbGeAlD
Amsacrine—NCOA3—Developmental Biology—VEGFA—melanoma	0.000112	0.000696	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—PTEN—melanoma	0.000112	0.000694	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—STAT3—melanoma	0.000111	0.00069	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—E2F1—melanoma	0.000111	0.000689	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—PTEN—melanoma	0.000111	0.000689	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—NRAS—melanoma	0.000111	0.000688	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—CASP8—melanoma	0.00011	0.000679	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—PRKCA—melanoma	0.000109	0.000675	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—CDKN2B—melanoma	0.000108	0.000671	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—MAPK3—melanoma	0.000106	0.000659	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	0.000105	0.000653	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—SLC15A2—melanoma	0.000105	0.00065	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—PCNA—melanoma	0.000105	0.00065	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—ABCB1—melanoma	0.000104	0.000642	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—TNF—melanoma	0.000103	0.000635	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—MAPK1—melanoma	0.000101	0.000627	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—EGFR—melanoma	0.000101	0.000627	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—SLC17A5—melanoma	0.000101	0.000625	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—CYP1B1—melanoma	0.0001	0.000621	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	9.98e-05	0.000618	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—E2F1—melanoma	9.95e-05	0.000616	CbGpPWpGaD
Amsacrine—KCNH2—Neuronal System—MDM2—melanoma	9.91e-05	0.000613	CbGpPWpGaD
Amsacrine—CYP2D6—Metapathway biotransformation—CYP1B1—melanoma	9.89e-05	0.000612	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—PRKCA—melanoma	9.75e-05	0.000603	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—melanoma	9.7e-05	0.000601	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—TNF—melanoma	9.64e-05	0.000597	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—CDK2—melanoma	9.6e-05	0.000594	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—KRAS—melanoma	9.56e-05	0.000592	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PRKCA—melanoma	9.55e-05	0.000591	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	9.49e-05	0.000588	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	9.49e-05	0.000588	CbGpPWpGaD
Amsacrine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—melanoma	9.49e-05	0.000587	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—ERCC2—melanoma	9.47e-05	0.000586	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—PCNA—melanoma	9.38e-05	0.000581	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—IFNG—melanoma	9.32e-05	0.000577	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—SLC6A11—melanoma	9.17e-05	0.000568	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—CDK4—melanoma	9.07e-05	0.000561	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—TERT—melanoma	9.06e-05	0.000561	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—melanoma	9.04e-05	0.00056	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	8.97e-05	0.000555	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—CXCL8—melanoma	8.66e-05	0.000536	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—CDK2—melanoma	8.58e-05	0.000531	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—CASP3—melanoma	8.29e-05	0.000513	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—IL6—melanoma	8.28e-05	0.000513	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—IL2—melanoma	8.28e-05	0.000513	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—melanoma	8.24e-05	0.00051	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	8.24e-05	0.00051	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—ATM—melanoma	8.14e-05	0.000504	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—HRAS—melanoma	8.13e-05	0.000503	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—melanoma	8.13e-05	0.000503	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—CDK4—melanoma	8.11e-05	0.000502	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—melanoma	7.97e-05	0.000493	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—RB1—melanoma	7.89e-05	0.000488	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	7.85e-05	0.000486	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—IL6—melanoma	7.78e-05	0.000482	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—FGF1—melanoma	7.73e-05	0.000479	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—TP53—melanoma	7.65e-05	0.000474	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—melanoma	7.57e-05	0.000469	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—melanoma	7.49e-05	0.000464	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PIK3CG—melanoma	7.48e-05	0.000463	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—PRKCA—melanoma	7.41e-05	0.000459	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—melanoma	7.27e-05	0.00045	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PPARG—melanoma	7.22e-05	0.000447	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—AKT1—melanoma	7.18e-05	0.000444	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—melanoma	7.14e-05	0.000442	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ACER3—melanoma	7.09e-05	0.000439	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—RB1—melanoma	7.05e-05	0.000437	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—VEGFA—melanoma	7.04e-05	0.000436	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—melanoma	7.01e-05	0.000434	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—IL6—melanoma	7e-05	0.000434	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—CDKN2A—melanoma	6.93e-05	0.000429	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—melanoma	6.87e-05	0.000426	CbGpPWpGaD
Amsacrine—KCNH2—Neuronal System—MAPK1—melanoma	6.77e-05	0.000419	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	6.73e-05	0.000417	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ACER3—melanoma	6.68e-05	0.000414	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PIK3CD—melanoma	6.58e-05	0.000407	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—melanoma	6.53e-05	0.000404	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—ALB—melanoma	6.49e-05	0.000402	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—UGT2B10—melanoma	6.49e-05	0.000402	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—CDKN2A—melanoma	6.2e-05	0.000384	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—melanoma	6.19e-05	0.000384	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	6.17e-05	0.000382	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—CDKN1B—melanoma	6.14e-05	0.00038	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—UGT2B10—melanoma	6.11e-05	0.000378	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—TNF—melanoma	6.03e-05	0.000373	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—HS3ST5—melanoma	6.03e-05	0.000373	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—MDM2—melanoma	6.01e-05	0.000372	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—CCND1—melanoma	5.86e-05	0.000363	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—melanoma	5.81e-05	0.00036	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—melanoma	5.74e-05	0.000355	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PIK3CB—melanoma	5.73e-05	0.000355	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—HS3ST5—melanoma	5.68e-05	0.000352	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PTGS2—melanoma	5.68e-05	0.000352	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—CDKN1A—melanoma	5.67e-05	0.000351	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—CDKN1B—melanoma	5.49e-05	0.00034	CbGpPWpGaD
Amsacrine—KCNH2—Neuronal System—HRAS—melanoma	5.44e-05	0.000337	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	5.41e-05	0.000335	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	5.32e-05	0.000329	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—CCND1—melanoma	5.24e-05	0.000324	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—AKT1—melanoma	5.18e-05	0.000321	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	5.14e-05	0.000318	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—CDKN1A—melanoma	5.07e-05	0.000314	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PTEN—melanoma	4.95e-05	0.000307	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	4.89e-05	0.000303	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—MAPK3—melanoma	4.83e-05	0.000299	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—MYC—melanoma	4.7e-05	0.000291	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	4.64e-05	0.000287	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—MAPK1—melanoma	4.6e-05	0.000285	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	4.57e-05	0.000283	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PLCB4—melanoma	4.57e-05	0.000283	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	4.51e-05	0.000279	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	4.41e-05	0.000273	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—MAPK3—melanoma	4.32e-05	0.000267	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PLCB4—melanoma	4.31e-05	0.000267	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PIP4K2A—melanoma	4.3e-05	0.000266	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—SLC6A11—melanoma	4.3e-05	0.000266	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—MYC—melanoma	4.2e-05	0.00026	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—SLC5A5—melanoma	4.19e-05	0.00026	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—MTAP—melanoma	4.18e-05	0.000259	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	4.18e-05	0.000259	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—MAPK1—melanoma	4.11e-05	0.000254	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	4.09e-05	0.000253	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—SLC6A11—melanoma	4.05e-05	0.000251	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PIP4K2A—melanoma	4.05e-05	0.000251	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	3.98e-05	0.000247	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	3.94e-05	0.000244	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—MTAP—melanoma	3.94e-05	0.000244	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	3.85e-05	0.000239	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	3.84e-05	0.000238	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	3.83e-05	0.000237	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PHGDH—melanoma	3.72e-05	0.000231	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—LUM—melanoma	3.72e-05	0.000231	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—HPSE—melanoma	3.65e-05	0.000226	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CUBN—melanoma	3.59e-05	0.000222	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PHGDH—melanoma	3.51e-05	0.000217	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—LUM—melanoma	3.51e-05	0.000217	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PIK3CA—melanoma	3.49e-05	0.000216	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	3.47e-05	0.000215	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—SDHD—melanoma	3.46e-05	0.000214	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CSPG4—melanoma	3.46e-05	0.000214	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—BSG—melanoma	3.46e-05	0.000214	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—TP53—melanoma	3.45e-05	0.000214	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—HPSE—melanoma	3.44e-05	0.000213	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CUBN—melanoma	3.38e-05	0.000209	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GPAM—melanoma	3.35e-05	0.000208	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	3.29e-05	0.000203	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—SDHD—melanoma	3.26e-05	0.000202	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—BSG—melanoma	3.26e-05	0.000202	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CSPG4—melanoma	3.26e-05	0.000202	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	3.2e-05	0.000198	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GPAM—melanoma	3.16e-05	0.000196	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	3.13e-05	0.000194	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	3.13e-05	0.000193	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	2.98e-05	0.000184	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	2.95e-05	0.000183	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—AKT1—melanoma	2.85e-05	0.000177	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PLA2G6—melanoma	2.85e-05	0.000177	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	2.71e-05	0.000168	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PLA2G6—melanoma	2.69e-05	0.000166	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	2.62e-05	0.000162	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—VCAN—melanoma	2.56e-05	0.000159	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—VCAN—melanoma	2.41e-05	0.000149	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	2.22e-05	0.000137	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CYP17A1—melanoma	2.16e-05	0.000134	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GNA11—melanoma	2.04e-05	0.000126	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CYP17A1—melanoma	2.04e-05	0.000126	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	2e-05	0.000124	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—FASN—melanoma	2e-05	0.000124	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—SLC5A5—melanoma	1.96e-05	0.000122	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GNA11—melanoma	1.92e-05	0.000119	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GNAQ—melanoma	1.9e-05	0.000117	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CD44—melanoma	1.9e-05	0.000117	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—FASN—melanoma	1.88e-05	0.000117	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—SLC5A5—melanoma	1.85e-05	0.000115	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CYP1B1—melanoma	1.82e-05	0.000113	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GNAQ—melanoma	1.79e-05	0.000111	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CD44—melanoma	1.79e-05	0.000111	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CYP1B1—melanoma	1.71e-05	0.000106	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ABCB1—melanoma	1.41e-05	8.74e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PRKCA—melanoma	1.38e-05	8.54e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ERCC2—melanoma	1.37e-05	8.47e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PRKCA—melanoma	1.3e-05	8.04e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ERCC2—melanoma	1.29e-05	7.98e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PIK3CG—melanoma	1.08e-05	6.69e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PPARG—melanoma	1.04e-05	6.45e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PIK3CG—melanoma	1.02e-05	6.3e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PPARG—melanoma	9.82e-06	6.08e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PIK3CD—melanoma	9.49e-06	5.88e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ALB—melanoma	9.37e-06	5.8e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PIK3CD—melanoma	8.95e-06	5.54e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ALB—melanoma	8.83e-06	5.47e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PIK3CB—melanoma	8.27e-06	5.12e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PTGS2—melanoma	8.2e-06	5.08e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PIK3CB—melanoma	7.8e-06	4.83e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PTGS2—melanoma	7.73e-06	4.78e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PTEN—melanoma	7.15e-06	4.43e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PTEN—melanoma	6.74e-06	4.17e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PIK3CA—melanoma	5.04e-06	3.12e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PIK3CA—melanoma	4.75e-06	2.94e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—AKT1—melanoma	4.12e-06	2.55e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—AKT1—melanoma	3.88e-06	2.4e-05	CbGpPWpGaD
